Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Prometrika, Medidata In Strategic Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Prometrika, Medidata In Strategic Pact

Joins Medidata’s Partner Program

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Prometrika has selected Medidata Solutions as a strategic partner to increase sponsor access to its range of clinical research services. Prometrika joined Medidata’s Partner Program and has committed to attain Rave accreditation for electronic data capture (EDC) and clinical data management (CDM).

Prometrika has a strong focus on biostatistics and data management, in addition to preparing FDA submissions and managing Phase I-IV trials across a range of therapeutic areas. Medidata’s Rave is a standards-based approach to structured data, which allows for conversions of Rave-centric data into datasets for statistical analysis.

“Medidata clearly understands the business and operational challenges faced by our customer base, new and established biotech companies that are working on some of the most innovative research in the world,” said Dr. Miganush Stepanians, president and chief executive officer of Prometrika. “We chose Medidata as a partner not only for its experience and expertise across the clinical development process, but also for its ability to help us continue to provide the most leading-edge technologies to our sponsor customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics